FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024384404> ?p ?o ?g. }

• W2024384404 endingPage "2360" @default.
• W2024384404 startingPage "2351" @default.
• W2024384404 abstract "Most epithelial ovarian tumors appear to arise from the ovarian surface epithelium (OSE). Even though it has been suggested that estrogen may be associated with ovarian tumorigenesis, the exact role of estrogen in the regulation of apoptosis in neoplastic OSE cells remains uncertain. Immortalized OSE (IOSE) cell lines were generated from human normal OSE. These cell lines represent early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and IOSE-29EC/T5) transformation stages from human normal OSE. The present studies demonstrated that both mRNAs and proteins of estrogen receptor (ER) alpha and beta were expressed in IOSE cell lines. No difference was observed in normal OSE and IOSE-29 cells, whereas treatment with 17beta-estradiol (E(2); 10(-8)-10(-6) M) resulted in an increased thymidine incorporation and DNA content per culture in IOSE-29EC cells. This effect of E(2) was attenuated with tamoxifen treatment (10(-6) M), the estrogen antagonist, suggesting that the effect of E(2) is mediated through specific ERs. There was no stimulatory effect on thymidine incorporation before day 6, but after 6 days of E(2) treatment, thymidine incorporation was significantly increased. Because the ratio of thymidine incorporation to DNA content per culture did not change, this E(2) effect does not appear to indicate stimulation of proliferation but, rather, inhibition of apoptosis. In addition, treatment with tamoxifen (10(-6) M) induced apoptosis up to 3-fold in IOSE-29EC cells, whereas cotreatment with E(2) (10(-8)-10(-6) M) plus tamoxifen attenuated tamoxifen-induced apoptosis in a dose-dependent manner. Both proapoptotic bax and antiapoptotic bcl-2 at messenger RNA (mRNA) and protein levels were expressed in IOSE cell lines. Interestingly, treatments with E(2) resulted in a significant increase of bcl-2 mRNA and protein levels (2- and 1.7-fold, respectively), whereas no difference was observed in bax mRNA level. Thus, E(2) may enhance survival of IOSE-29EC by up-regulating bcl-2, and antiapoptotic bcl-2 may be a dominant regulator of apoptotic pathway in these cells. In conclusion, the present study indicates that early neoplastic (IOSE-29), tumorigenic (IOSE-29EC), and late neoplastic (IOSE-29EC/T4 and T5) OSE cells expressed both ERalpha and ERbeta at the mRNA and protein levels. In addition, E(2) prevented tamoxifen induced-apoptosis through ERs. The mechanism of E(2) action may be associated with up-regulation of bcl-2 gene at mRNA and protein levels. These results suggest that estrogen may play a role in ovarian tumorigenesis by preventing apoptosis in tumorigenic OSE cells." @default.
• W2024384404 created "2016-06-24" @default.
• W2024384404 creator A5021792205 @default.
• W2024384404 creator A5024860849 @default.
• W2024384404 creator A5058592673 @default.
• W2024384404 creator A5059854070 @default.
• W2024384404 creator A5067567295 @default.
• W2024384404 date "2001-06-01" @default.
• W2024384404 modified "2023-10-03" @default.
• W2024384404 title "Estradiol Up-Regulates Antiapoptotic Bcl-2 Messenger Ribonucleic Acid and Protein in Tumorigenic Ovarian Surface Epithelium Cells*" @default.
• W2024384404 cites W1486894501 @default.
• W2024384404 cites W1538903611 @default.
• W2024384404 cites W1858696345 @default.
• W2024384404 cites W1966620203 @default.
• W2024384404 cites W1967387654 @default.
• W2024384404 cites W1973036015 @default.
• W2024384404 cites W1974841944 @default.
• W2024384404 cites W1975557160 @default.
• W2024384404 cites W1978362571 @default.
• W2024384404 cites W1979107980 @default.
• W2024384404 cites W1980201215 @default.
• W2024384404 cites W1981306061 @default.
• W2024384404 cites W1987220103 @default.
• W2024384404 cites W1987324195 @default.
• W2024384404 cites W1991038291 @default.
• W2024384404 cites W1993879220 @default.
• W2024384404 cites W1997425090 @default.
• W2024384404 cites W2022653694 @default.
• W2024384404 cites W2029327979 @default.
• W2024384404 cites W2035769567 @default.
• W2024384404 cites W2042928863 @default.
• W2024384404 cites W2043900159 @default.
• W2024384404 cites W2049769334 @default.
• W2024384404 cites W2059561866 @default.
• W2024384404 cites W2073353512 @default.
• W2024384404 cites W2077697209 @default.
• W2024384404 cites W2077839741 @default.
• W2024384404 cites W2080673878 @default.
• W2024384404 cites W2085776836 @default.
• W2024384404 cites W2087109466 @default.
• W2024384404 cites W2093957373 @default.
• W2024384404 cites W2104763359 @default.
• W2024384404 cites W2124221273 @default.
• W2024384404 cites W2127720974 @default.
• W2024384404 cites W2128840922 @default.
• W2024384404 cites W2130294911 @default.
• W2024384404 cites W2137849078 @default.
• W2024384404 cites W2148976855 @default.
• W2024384404 cites W2161623422 @default.
• W2024384404 cites W2398550709 @default.
• W2024384404 cites W4229662680 @default.
• W2024384404 doi "https://doi.org/10.1210/endo.142.6.8144" @default.
• W2024384404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11356682" @default.
• W2024384404 hasPublicationYear "2001" @default.
• W2024384404 type Work @default.
• W2024384404 sameAs 2024384404 @default.
• W2024384404 citedByCount "89" @default.
• W2024384404 countsByYear W20243844042012 @default.
• W2024384404 countsByYear W20243844042013 @default.
• W2024384404 countsByYear W20243844042014 @default.
• W2024384404 countsByYear W20243844042015 @default.
• W2024384404 countsByYear W20243844042016 @default.
• W2024384404 countsByYear W20243844042017 @default.
• W2024384404 countsByYear W20243844042018 @default.
• W2024384404 countsByYear W20243844042020 @default.
• W2024384404 countsByYear W20243844042022 @default.
• W2024384404 countsByYear W20243844042023 @default.
• W2024384404 crossrefType "journal-article" @default.
• W2024384404 hasAuthorship W2024384404A5021792205 @default.
• W2024384404 hasAuthorship W2024384404A5024860849 @default.
• W2024384404 hasAuthorship W2024384404A5058592673 @default.
• W2024384404 hasAuthorship W2024384404A5059854070 @default.
• W2024384404 hasAuthorship W2024384404A5067567295 @default.
• W2024384404 hasBestOaLocation W20243844041 @default.
• W2024384404 hasConcept C104317684 @default.
• W2024384404 hasConcept C121608353 @default.
• W2024384404 hasConcept C126322002 @default.
• W2024384404 hasConcept C134018914 @default.
• W2024384404 hasConcept C190283241 @default.
• W2024384404 hasConcept C2777108182 @default.
• W2024384404 hasConcept C2777164284 @default.
• W2024384404 hasConcept C2777176818 @default.
• W2024384404 hasConcept C2993273003 @default.
• W2024384404 hasConcept C31033888 @default.
• W2024384404 hasConcept C502942594 @default.
• W2024384404 hasConcept C529295009 @default.
• W2024384404 hasConcept C530470458 @default.
• W2024384404 hasConcept C54355233 @default.
• W2024384404 hasConcept C552990157 @default.
• W2024384404 hasConcept C55493867 @default.
• W2024384404 hasConcept C555283112 @default.
• W2024384404 hasConcept C62112901 @default.
• W2024384404 hasConcept C71924100 @default.
• W2024384404 hasConcept C81885089 @default.
• W2024384404 hasConcept C86803240 @default.
• W2024384404 hasConcept C95444343 @default.
• W2024384404 hasConceptScore W2024384404C104317684 @default.
• W2024384404 hasConceptScore W2024384404C121608353 @default.

• next